Early diagnosis remains the single factor that most impacts cure rates
Todo mês de junho, o Brasil volta sua atenção para o câncer de pele — a malignidade mais comum do país, responsável por 30% de todos os tumores, e ainda assim frequentemente subestimada. A campanha Junho Preto existe precisamente para confrontar esse paradoxo: uma doença tão prevalente quanto pouco levada a sério, tratada como preocupação estética quando deveria ser encarada como ameaça real. O que a ciência confirma, e o que oncologistas repetem, é que o tempo é o fator decisivo — diagnosticado cedo, o câncer de pele é, na maioria dos casos, curável.
- O câncer de pele lidera as estatísticas oncológicas brasileiras, mas segue invisível no imaginário popular — muitos só o reconhecem quando já avançou.
- Sinais sutis como feridas que não cicatrizam, manchas que mudam de forma e lesões que sangram são ignorados por falta de informação, abrindo caminho para diagnósticos tardios.
- O melanoma, menos frequente mas mais agressivo, pode se disseminar para órgãos distantes quando não detectado a tempo, exigindo tratamentos complexos e de alto custo.
- Avanços recentes em imunoterapia e terapia-alvo ampliam as opções para casos avançados, mas especialistas são enfáticos: nenhuma inovação supera o valor da detecção precoce.
- O Junho Preto mobiliza profissionais e instituições para transformar comportamento: usar protetor solar diariamente, evitar o sol no horário de pico e consultar o dermatologista regularmente são os gestos que mais salvam vidas.
O câncer de pele é a malignidade mais frequente no Brasil — cerca de 30% de todos os tumores malignos registrados no país, segundo o Instituto Nacional do Câncer. Ainda assim, persiste um paradoxo inquietante: justamente a doença que mais acomete brasileiros é também uma das mais subestimadas, tratada por muitos como questão menor ou meramente estética.
O oncologista Gustavo Vasili Lucas, do Instituto Paranaense de Oncologia, aponta o equívoco central: a maioria das pessoas imagina que o câncer de pele se anuncia de forma óbvia. Na prática, os sinais costumam ser discretos — uma ferida que não fecha, uma mancha que muda de aparência, uma lesão que cresce gradualmente. Ignorados, esses sinais podem custar caro. 'O diagnóstico precoce é o fator que mais impacta as taxas de cura', afirma Lucas.
A doença se divide em dois grandes grupos. Os tumores não melanoma representam a maioria dos casos e tendem a ser menos agressivos. O melanoma, embora menos comum, é o tipo mais perigoso, com capacidade de se disseminar para órgãos distantes. Para identificá-lo, especialistas recomendam a regra ABCDE: assimetria, bordas irregulares, cores variadas, diâmetro aumentado e evolução ao longo do tempo.
O tratamento varia conforme o tipo e o estágio. Cirurgia de remoção resolve a maioria dos casos iniciais. Em situações avançadas, recorre-se à imunoterapia, terapia-alvo, radioterapia ou quimioterapia — recursos que evoluíram significativamente nos últimos anos, especialmente para o melanoma avançado. Mesmo assim, Lucas é claro: nenhum avanço terapêutico substitui o benefício de encontrar a doença cedo.
A prevenção segue sendo o caminho mais eficaz. A exposição excessiva à radiação ultravioleta é o principal fator de risco, ao lado de histórico familiar, pele clara, muitas pintas e uso de câmaras de bronzeamento artificial. O Junho Preto reforça uma mensagem direta: protetor solar diário, roupas de proteção, evitar o sol entre 10h e 16h e consultas regulares ao dermatologista são, juntos, a estratégia mais poderosa para reduzir o impacto do câncer de pele e preservar vidas.
Skin cancer is the most common malignancy in Brazil, yet it remains profoundly underestimated. The disease accounts for roughly 30 percent of all malignant tumors recorded in the country, according to the National Cancer Institute, a statistic that underscores why awareness campaigns like Junho Preto—Black June—exist at all. The paradox is stark: the illness that affects more Brazilians than any other cancer type is often dismissed as minor, a cosmetic concern rather than a serious threat.
The reality is more complicated. When skin cancer goes undetected or untreated, it can produce grave consequences. But here is the counterweight: most cases respond well to treatment when caught early. The disease's trajectory depends almost entirely on timing. Gustavo Vasili Lucas, an oncologist at the Paraná Institute of Oncology, points to a persistent misconception that clouds public understanding. Many people assume skin cancer announces itself as a dark mole or an unmistakable lesion. In fact, the warning signs are often subtler—a wound that refuses to heal, a patch that shifts in appearance, a growth that expands over weeks. These deserve medical investigation, yet many people ignore them. Lucas identifies the core challenge: convincing the population to observe their own skin carefully and adopt preventive habits. "Early diagnosis remains the single factor that most impacts cure rates," he says.
The disease emerges when skin cells begin multiplying in disordered fashion, forming tumors. It strikes most often in areas regularly exposed to sunlight—the face, scalp, neck, arms, legs. Two main categories exist. Non-melanoma tumors make up the majority of cases and are generally less aggressive. Melanoma, by contrast, is the more dangerous variant, capable of spreading to distant organs. Though less common, melanoma demands particular vigilance. When identified in early stages, it carries high cure rates. Diagnosed late, it requires complex interventions.
Certain signs warrant immediate attention. A wound that does not heal. A patch that grows larger. A mole that shifts in color, shape, or thickness. A lesion that bleeds easily. Skin that flakes persistently. Itching or sensitivity that lingers in one area. For melanoma specifically, specialists recommend watching for what they call the ABCDE rule: asymmetry, irregular borders, uneven color, increased diameter, and evolution over time.
Treatment depends on the cancer's type and stage. Surgery to remove the lesion often suffices. In advanced cases, doctors may turn to immunotherapy, targeted therapy, radiation, or chemotherapy. Recent years have brought significant advances in oncology, particularly for patients with advanced melanoma. Treatment has become increasingly personalized and effective. Yet Lucas emphasizes that no innovation surpasses the benefit of early detection. The sooner the disease is identified, the higher the cure rate and the less burdensome the treatment.
Prevention remains the most reliable path. Excessive ultraviolet radiation exposure stands as the primary risk factor. Family history, fair skin, numerous moles, frequent sunburns, and artificial tanning beds all elevate risk. Specialists recommend daily sunscreen use, avoiding sun exposure between 10 a.m. and 4 p.m., wearing hats and UV-protective clothing and sunglasses, reapplying sunscreen throughout the day, and scheduling regular dermatological checkups. This Junho Preto carries a straightforward message: information, prevention, and early diagnosis remain the most powerful tools for reducing skin cancer's impact and preserving life.
Notable Quotes
Many people believe skin cancer always appears as a dark mole or obvious lesion, but non-healing wounds, changing patches, and progressive growths also warrant medical investigation— Gustavo Vasili Lucas, oncologist at the Paraná Institute of Oncology
No medical advance surpasses the benefit of early detection—the sooner the disease is identified, the higher the cure rate and the less burdensome the treatment— Gustavo Vasili Lucas
The Hearth Conversation Another angle on the story
Why does skin cancer remain underestimated when it's the most common malignancy in Brazil?
People tend to think of cancer as something dramatic and obvious. A dark mole, a visible wound. But skin cancer often whispers before it shouts. A patch that changes slowly, a lesion that doesn't quite heal. By the time someone takes it seriously, months may have passed.
So the problem is partly about what people expect to see?
Exactly. There's a mental image of what cancer "looks like," and skin cancer doesn't always match it. That gap between expectation and reality is where cases slip through undiagnosed.
The article mentions that early detection changes everything. How dramatic is that difference?
It's the difference between a simple surgical removal and complex systemic treatment. Early melanoma can be cured. Late melanoma demands immunotherapy, targeted drugs, sometimes chemotherapy. The body endures far more.
What makes melanoma different from the other types?
It's the aggression. Non-melanoma tumors stay mostly local. Melanoma travels. It can reach the lungs, the liver, the brain. That's why the ABCDE rule exists—to catch it before it spreads.
If prevention is so effective, why isn't everyone doing it?
Sunscreen feels tedious. Avoiding midday sun feels restrictive. People don't connect a day at the beach to a diagnosis years later. Prevention requires discipline without immediate reward.
What should someone do if they notice something on their skin?
See a dermatologist. Not next month. Soon. A professional can distinguish between a harmless mole and something that needs attention. That conversation, that early look, can reshape everything.